TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Entero Therapeutics ( (ENTO) ) has provided an update.
On October 17, 2025, the stockholders of GridAI Corp waived their right to appoint two directors to Entero Therapeutics, Inc.’s Board of Directors. This decision will remain in effect until the shareholders of Entero Therapeutics approve the appointment of such directors at a future meeting, impacting the company’s governance structure.
More about Entero Therapeutics
Average Trading Volume: 1,820,766
Technical Sentiment Signal: Hold
Current Market Cap: $6.45M
For an in-depth examination of ENTO stock, go to TipRanks’ Overview page.